Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-10

Clinical Trial Update: Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the diuretic and natriuretic effects of high-dose spironolactone in patients with acute heart failure and decompensation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Laikο General Hospital, Athens | Conditions: Heart Failure Acute, Heart Failure; With Decompensation | Phase 4 | Status: UNKNOWN